ClinicalTrials.gg
RecruitingNCT07560904DEEPBRAINUpdated May 1, 2026

Non-invasive Stimulation of Deep Brain Structures to Modulate Working Memory

An interventional study of Non-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (20 Hz) and Control striatal stimulation in Older Adults (60 - 85 Years Old) and Mild Cognitive Impairment (MCI), sponsored by Masaryk University. Recruiting at 1 site in Czechia. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by Masaryk University · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Cognitive Dysfunction with a site in Czechia — 10 open to participants now, 14 under way, 2 of them phase 3. Cognitive Dysfunction · Czechia.

Planned enrollment
16th of 30
70 · median 80
Started
2026
with 4 others
No phase
18 of 36
6 open now
Primary completion
2026-07
later than 7 of 13 live
Registered
35th of 36
by date
Lead sponsor
8 of 36
Masaryk University

Among the 36 studies in Cognitive Dysfunction with a site in Czechia, this one is the 16th largest by planned enrollment of the 30 interventional ones that give a count, is one of 5 that started in 2026, is one of 18 with no phase, reaches primary completion later than 7 of the 13 other live ones, and was the 35th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

10 of the 36 studies in Cognitive Dysfunction with a site in Czechia are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 60 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Cognitive Dysfunction with a site in Czechia, or all of them as a file.
02

Study summary

A study investigating the effects of non-invasive electrical stimulation of deep brain structures on working memory, attention, and executive functions involved in everyday activities. Currently, there is no effective treatment for impairments in these functions. The study will evaluate the effects of non-invasive electrical stimulation in both healthy older adults and individuals with mild impairment of these functions.

The study combines magnetic resonance imaging (MRI) with non-invasive brain stimulation targeting deep brain structures. Its aim is to improve understanding of the neural mechanisms underlying these cognitive functions and their impairments, as well as to explore the mechanisms of non-invasive brain stimulation for potential future therapeutic applications.

03

Conditions studied

  • Older Adults (60 - 85 Years Old)
  • Mild Cognitive Impairment (MCI)
04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • normal cognitive performance as assessed by a cognitive screening for healthy subjects
  • possible or probable MCI-LB or with PD-MCI, collectively called MCI-LBD, described as: presence of PD , and level II criteria for MCI (i.e. based on comprehensive neuropsychological examination), or the level II criteria for MCI , and at least two of four core DLB features including parkinsonism, visual hallucinations, attention/cognitive function fluctuation, and REM sleep behavioral disorder, or at least 1 core clinical feature and 1 indicative biomarker (probable MCI-LB).

Exclusion criteria

Exclusion Criteria:

  • Psychiatric disorders including major depression, major vascular lesions, or other brain pathologies that might present with cognitive decline.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    20 Hz striatal stimulation

    Striatum will be targeted by using two pairs of high-frequency tES with a low-frequency offset (20 Hz), creating an interference hotspot targeting the deep brain structure (deep-tES).

    Other: Non-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (20 Hz)

  • Experimental
    60 Hz striatal stimulation

    Striatum will be targeted by using two pairs of high-frequency tES with a low-frequency offset (60 Hz), creating an interference hotspot targeting the deep brain structure (deep-tES).

    Other: Non-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (60 Hz)

  • Sham comparator
    Sham striatal stimulation

    Striatum will be targeted by using two pairs of high-frequency tES with no low-frequency offset. The stimulation will be applied only shortly and turned off after ramp-up and ramp-down period.

    Other: Control striatal stimulation

Interventions

  • OtherNon-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (20 Hz)

    Striatum will be targeted by using at least two pairs of high-frequency tES with a low-frequency (20 Hz) offset, creating an interference hotspot targeting the deep brain structure (deep-tES).

  • OtherControl striatal stimulation

    A high-frequency tES without low-frequency offset. It will consist of two oscillatory high-frequency currents without any frequency shifts, which induces similar skin sensations as deep-tES and will be applied just for a ramp-up/ramp-down phases at the beginning of the stimulation and afterwards will be switched off.

  • OtherNon-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (60 Hz)

    Striatum will be targeted by using at least two pairs of high-frequency tES with a low-frequency (60 Hz) offset, creating an interference hotspot targeting the deep brain structure (deep-tES).

06

What researchers measure

Primary outcomes

  1. The neural underpinning of NIBS-induced changes quantified by task-fMRI activations

    Time frame: During intervention ( approximately 10 minutes)

  2. The neural underpinning of NIBS-induced changes quantified by network-based analytical approaches.

    Time frame: During intervention ( approximately 10 minutes)

Secondary outcomes

  1. Working memory performance - Reaction times

    Reaction times of an N-back task between the real and sham stimulation condition in a cross-over design.

    Time frame: During intervention (approx 10 minutes)

  2. Working memory parformance - Accuracy

    Accuracy (measured as D-prime) of an N-back task between the real and sham stimulation condition in a cross-over design.

    Time frame: During intervention ( approximately 10 minutes)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Jul 2026, 4 months after the start.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 4 months is below that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2026
First posted
May 1, 2026
StartActual
Mar 1, 2026
Primary completionEst.
Jul 2026
CompletionEst.
Jul 2026
Last update
May 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07560904
Lead sponsor
Masaryk University
Responsible party
Monika Pupikova (prof. Irena Rektorová MD, Ph.D., Masaryk University) — Principal investigator
First posted
May 1, 2026
Start date
Mar 1, 2026
Primary completion
Jul 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
May 1, 2026

Study contacts

Monika Pupíková
Contact
monika.pupikova@ceitec.muni.cz
+420549498818

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion